Research Directory

COVID-19's logistical impact on advanced therapies

Read more

Solving the viral vector bottleneck during a pandemic

Read more

The changing landscape for haemophilia treatment

Read more

Meeting the challenge of viral vector manufacture

Read more

Human gene therapy - immunogenicity perspective

Read more

A bioethical framework for therapeutic gene editing

Read more

The precedents set by Zolgensma

Read more

Advanced therapy financing events in Q1 2019

Read more

Microsoft pioneers biological computing

Read more

Will gene editing unmask synthetic lethal targets?

Read more